donateHelp Us Fight MG

 

Ra Pharmaceuticals Announces Positive Top-­‐line Data from Phase 2 Trial of Zilucoplan in Patients with Generalized Myasthenia Gravis

Download ra_pharmaceuticals_announces_positive_top-line_data_from_phase_2_trial_of_zilucoplan_in_patients_with_generalized_myasthenia_gravis.pdf (173.42 kb)

 

Bank Of The West Building

6055 E. Washington Blvd.
Suite #350
Los Angeles, California 90040

Phone: (323) 887-0056

  Follow Us

  Connect With Us

©2024 Myasthenia Gravis Foundation of California.